Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Its a game changer
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: a model-based cost-effectiveness analysis using real-world data
National Aeronautics and Space Administration NASA/TP-2013-217375 (2013)
By the time Novo reconsidered, Lillys retatrutide (originating from the same idea) had surged ahead in development
What Are the Key Dates to Know
Retatrutide activates three hormone receptors at once: GLP-1R (reduces appetite, stimulates insulin), GIPR (boosts insulin and modulates appetite via a separate brain pathway), and GCGR (increases calorie burning and fat breakdown)
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
